MICA Artificial Intelligence and Baptist Health South Florida announced an exciting collaboration and licensing agreement to improve the way mammograms are evaluated, helping doctors detect breast cancer earlier and more accurately.
Medical Director Dr. Kathy Schilling and Director Shakira Sarquis-Kolber of The Christine E. Lynn Women’s Health & Wellness Institute at Boca Raton Regional Hospital, part of Baptist Health South Florida, are the leading experts in this project. The Institute provides comprehensive care addressing women’s unique medical needs throughout their lives, featuring advanced imaging technology and same-day mammography results.
This collaboration was developed with Sheba Medical Center’s ARC (Accelerate, Redesign, Collaborate) start-up ecosystem, where MICA AI was created and tested in the hospital’s Meirav Breast Cancer Center. MICA AI uses advanced technology to help radiologists analyze mammograms more effectively. One of its key innovations is a special method for Contrast Enhanced Mammography (CEM), which usually requires an iodine injection.
The new AI system aims to provide similar information about blood supply in the breasts without the need for injections or additional procedures. It can also enhance mammogram images that are difficult to read due to dense breast tissue. As it processes more data, it becomes better at producing clearer images, allowing doctors to identify potential problems more easily.
MICA AI plans to integrate its technology into mammogram machines from various manufacturers. This collaboration with Baptist Health South Florida aims to bring this cutting-edge innovation to the U.S. market, benefiting breast cancer patients nationwide.
“This is an exciting example of how Baptist Health Innovations is accelerating innovation through our relationship with Sheba Medical Center and ARC together with MICA AI to bring advanced solutions in cancer therapy for our patients by facilitating collaboration between our subject matter experts and advanced technology companies,” said Barry T. Katzen, M.D., Chief Medical Innovation Officer of Baptist Health South Florida.
“Artificial intelligence has great potential to improve cancer diagnosis and treatment,” said Professor Eyal Zimlichman, Director of ARC and Chief Innovation & Transformation Officer at Sheba Medical Center. “This collaboration will help introduce this groundbreaking technology to the U.S., transforming breast cancer care.”
